Answers are grounded in this paper and cite their sources.
Background: Diabetes mellitus (DM) is a chronic endocrine disorder characterised by impaired glucose and lipid metabolism, resulting in hyperglycaemia, insulin resistance, and endocrine dysfunction. Current treatments mainly focus on glycaemic control, often neglecting interconnected signalling pathways that are essential for metabolic homeostasis and personalised therapy.Methods This study proposes a pathway-specific metabolic regulatory framework (PSMRF) that integrates pathway-centric metabolic analysis with intelligent optimisation to regulate dysregulated glucose and lipid metabolism. The framework includes metabolic biomarker preprocessing, pathway interaction modelling, multi-pathway optimisation, and XGBoost-based prediction. Using clinical biomarkers, including fasting blood glucose, HbA1c, insulin sensitivity, lipid profile, inflammatory markers, and endocrine indices, it simultaneously regulates insulin, AMP-activated protein kinase (AMPK), phosphoinositide 3-kinase/protein kinase B (PI3K/Akt), peroxisome proliferator-activated receptors (PPARs), and mammalian target of rapamycin (mTOR) pathways.Context Experimental results demonstrated that the proposed PSMRF achieved 99.18% prediction accuracy, with an insulin sensitivity improvement (ISI) score of 93.74%, outperforming the comparative machine-learning models and demonstrating improved computational assessment of metabolic regulation.
No takes yet. Share an insight, caveat, or question.
Ya et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: